A Study of LY3537021 in Healthy Participants

NCT05444569 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3537021
DRUG: Liraglutide
DRUG: Placebo

Sponsor

Eli Lilly and Company